择期骨科手术中2-辛基氰基丙烯酸酯皮肤闭合所致过敏性接触性皮炎的诊断与治疗特征分析
回顾性分析2013至2016年29例择期骨科术后对2-辛基氰基丙烯酸酯(Prineo)发生过敏性接触性皮炎(ACD)的患者,估计发生率为0.5%。多数反应为中重度(48%中度、38%重度),诊断距手术平均11.8天,所有病例经移除敷料、每日换药及必要时口服抗组胺药或皮质类固醇后,于术后平均22天消退。
要点
- 2-辛基氰基丙烯酸酯皮肤粘合剂所致ACD估计发生率为0.5%。
- 多数反应为中重度(48%中度、38%重度),诊断距手术平均11.8天。
- 所有病例经移除敷料和换药后于术后平均22天消退,未显著影响伤口愈合。
核心结论
- 2-辛基氰基丙烯酸酯皮肤粘合剂在骨科手术中使用时估计0.5%的病例发生ACD,可导致严重的术后过敏性接触性皮炎;但通过早期识别和适当治疗,患者症状消退且对伤口愈合无显著影响。
研究设计与样本
- 回顾性分析2013年至2016年在本机构使用Prineo(Ethicon,NJ)的6088个单位中29例发生ACD的择期骨科手术患者,估计发生率为0.5%。
- 29例患者中19例(66%)为膝关节手术,平均年龄55岁(范围15-92岁)。
- 根据症状严重程度和治疗需求将患者分为轻度、中度和重度反应。
主要发现
- 多数反应为中度(48%)或重度(38%)。
- 从手术到诊断的平均时间为11.8天(范围2-42天)。
- 20例(69%)接受口服抗组胺药,16例(55%)需要局部皮质类固醇,5例(17%)需要口服皮质类固醇。
- 所有ACD病例最终在术后平均22天(范围13-56天)消退。
关键数值与推荐
- 29例患者中19例(66%)为膝关节手术。
- 20例(69%)接受口服抗组胺药,16例(55%)需要局部皮质类固醇,5例(17%)需要口服皮质类固醇。
- 所有病例在术后平均22天(范围13-56天)消退。
临床怎么用
- 所有患者均接受移除Prineo敷料并按特定方案每日换药。
- 20例(69%)接受口服抗组胺药,16例(55%)需要局部皮质类固醇,5例(17%)需要口服皮质类固醇。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While studies have shown that postoperative wound complications can predispose to deep infection following orthopedic surgery, the best form of skin closure has not been elucidated. Furthermore, the unique risks and benefits of each type of wound closure have not been studied. The goal of this study is to present the diagnosis and treatment of patients with allergic contact dermatitis (ACD) from 2-octyl cyanoacrylate, a skin adhesive commonly used in wound closure. METHODS: Twenty-nine patients with ACD to 2-octyl cyanoacrylate (Prineo, Ethicon, NJ) following elective orthopedic surgeries from 2013 to 2016 were retrospectively reviewed; this occurred in 29 of 6088 units of Prineo used at our institution, for an estimated incidence of 0.5%. Nineteen patients (66%) had knee operations. Mean age was 55 years (range, 15-92 years). We classified patients by symptom severity and treatment requirements into mild, moderate, and severe reactions. RESULTS: Most reactions were moderate (48%) or severe (38%) reactions. Mean time from surgery to diagnosis was 11.8 days (range, 2-42 days). All patients underwent removal of the Prineo dressing and daily dressing changes with a specific protocol. Twenty patients (69%) received oral antihistamines, 16 patients (55%) required topical corticosteroids, and 5 patients (17%) required oral corticosteroids. All cases of ACD ultimately resolved at a mean of 22 days (range, 13-56 days) postoperatively. CONCLUSION: 2-Octyl cyanoacrylate skin adhesive occurs in an estimated 0.5% of cases and can lead to severe postoperative ACD when used following orthopedic operations. However, with early recognition and appropriate treatment, patients' symptoms resolve without a significant impact on wound healing.
引用
- Chalmers BP, Melugin HP, Sculco PK, et al. Characterizing the Diagnosis and Treatment of Allergic Contact Dermatitis to 2-Octyl Cyanoacrylate Used for Skin Closure in Elective Orthopedic Surgery. J Arthroplasty. 2017. PMID: 28811110. doi:10.1016/j.arth.2017.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。